What “Potency” Really Means When Choosing a Compounding Pharmacy
If you’re on a compounded GLP-1 medication, or writing scripts for patients who are, you’ve probably noticed the market got crowded fast. Not every compounding pharmacy sources or tests the same way, and those differences don’t show up on the label.
Where the medication actually comes from
Every compounded semaglutide or tirzepatide formulation starts with an active pharmaceutical ingredient (API) sourced from somewhere. At Pharmaconic, that somewhere is an FDA-greenlisted vendor — not an unverified third-party reseller, and not product passed along from a 503B outsourcing facility without independent verification.
A growing number of compounding pharmacies resell product they didn’t source or test themselves. When that happens, nobody downstream — including the prescriber writing the script — can confirm the vial matches the label.
Third-party testing, not just an internal claim
Every active compound we produce is third-party tested, and a certificate of analysis (COA) is available on request for any patient or prescriber who asks. You don’t have to take our word for potency — you can see the test.
Our sterile compounding suite follows USP 795, 797, and 800 standards, with clean-room testing completed before any new production run begins. For patients, that means the formulation you’re injecting was built to a verified standard. For prescribers, that means you can stand behind what you prescribe.
On peptides: green-listed and approved sourcing only
We’re seeing a lot of interest in peptides beyond GLP-1 — recovery, longevity, general wellness formulations. Here’s our line: Pharmaconic compounds peptides sourced only from FDA-greenlisted, approved suppliers. We do not offer research-only peptides.
“Research chemical” grade peptides aren’t manufactured to pharmaceutical standards, aren’t intended for human use, and carry no verified purity or sterility assurance. If a peptide isn’t sourced the same way we source semaglutide and tirzepatide — verified vendor, tested API, documented chain of custody — we don’t carry it.
If you’re a patient: ask your pharmacy where their API comes from and whether a COA is available. That’s a fair question, and a pharmacy that stands behind its process should have a straightforward answer.
If you’re a prescriber: the same question applies to every compounding partner you work with. Patient-specific formulations only work as intended when the sourcing and testing behind them are verifiable, not assumed.
This is general educational information, not individual medical advice. Talk to your prescriber about whether a compounded formulation is appropriate for you.
Compounded medications are patient-specific preparations and are not FDA-approved finished drug products. All formulations require a valid prescription from a licensed prescriber.